5 Practical Ways GMP Manufacturers Can Start Improving Asset Performance Today

In a GMP environment, asset performance is inseparable from compliance. Equipment failures or subtle calibration drift don’t just interrupt production—they introduce deviations that can compromise batch integrity and trigger regulatory scrutiny. As FDA enforcement activity increased in 2025, maintenance and calibration gaps emerged repeatedly in warning letters and Form 483 observations, often tied to incomplete records, missed preventive maintenance, or unverifiable asset history. Controlling asset performance means more than keeping machines running. It requires demonstrable oversight of equipment health, clear evidence that assets remain within specification, and maintenance practices that stand up to inspection. When assets are managed effectively, manufacturers reduce deviation risk, protect product quality, and enter audits with confidence.

Explore how disciplined asset performance strategies help strengthen quality systems and reduce regulatory exposure.